Create Free Account

By creating account you will get access to hot stocks & personalised emails

Pro Medicus Ltd

Healthcare AU PME

112.1AUD
2.85(2.61%)

Last update at 2024-05-02T06:10:00Z

Day Range

109.39112.59
LowHigh

52 Week Range

58.36112.59
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 86.13M 63.08M 42.87M 30.02M 26.12M
Minority interest - - - - -
Net income 60.65M 44.44M 30.85M 23.08M 23.08M
Selling general administrative 24.07M 15.40M 13.53M 12.85M 12.13M
Selling and marketing expenses 2.52M 1.95M 0.32M 1.49M 1.57M
Gross profit 124.24M 92.94M 67.35M 56.42M 48.67M
Reconciled depreciation 7.93M 7.32M 7.20M 7.68M 6.08M
Ebit 83.76M 62.33M 42.33M 30.02M 25.44M
Ebitda 91.69M 69.64M 49.53M 37.71M 31.52M
Depreciation and amortization 7.93M 7.32M 7.20M 7.68M 6.08M
Non operating income net other - - - - -
Operating income 84.08M 61.31M 42.63M 30.07M 25.44M
Other operating expenses 40.12M 30.10M 24.21M 26.26M 24.64M
Interest expense 0.39M 0.65M 0.54M 0.00500M 0.68M
Tax provision 25.48M 18.64M 12.02M 6.94M 7.00M
Interest income 2.43M 0.65M 0.18M 0.17M 0.24M
Net interest income 2.43M 0.65M 0.18M 0.17M 0.24M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 25.48M 18.64M 12.02M 6.94M 7.00M
Total revenue 124.79M 93.40M 67.84M 56.78M 50.08M
Total operating expenses 40.48M 30.61M 25.01M 26.40M 23.23M
Cost of revenue 0.54M 0.47M 0.49M 0.35M 1.41M
Total other income expense net -0.06600M 0.10M 0.36M -0.17700M 0.68M
Discontinued operations - - - - -
Net income from continuing ops 60.65M 44.44M 30.85M 23.08M 19.12M
Net income applicable to common shares 60.65M 44.44M 30.85M 23.08M 19.12M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 202.13M 157.05M 125.57M 95.64M 84.28M
Intangible assets 21.35M 22.29M 20.01M 18.84M 18.17M
Earning assets - - - - -
Other current assets 0.78M 0.45M 1.57M 1.03M 1.99M
Total liab 63.36M 55.32M 43.89M 35.46M 34.99M
Total stockholder equity 138.78M 101.73M 81.68M 60.18M 49.29M
Deferred long term liab 2.36M 1.47M 1.35M 0.76M -
Other current liab 16.56M 14.48M 7.29M 4.13M 5.07M
Common stock 1.96M 1.96M 1.96M 1.96M 1.96M
Capital stock 1.96M 1.96M 1.96M 1.96M 1.96M
Retained earnings 127.12M 92.58M 66.92M 49.62M 37.46M
Other liab 31.31M 26.78M 24.23M 20.99M 21.07M
Good will - - - - -
Other assets 12.45M 47.19M 43.03M 40.53M 36.84M
Cash 91.25M 63.66M 42.04M 43.41M 32.31M
Cash and equivalents - - - - -
Total current liabilities 30.85M 26.86M 17.62M 12.72M 13.92M
Current deferred revenue 12.60M 10.13M 8.89M 7.22M 7.63M
Net debt -89.39700M -61.37700M -39.42100M -41.13700M -30.03900M
Short term debt 0.65M 0.60M 0.57M 0.52M 0.52M
Short long term debt - - - - -
Short long term debt total 1.85M 2.28M 2.62M 2.28M 2.28M
Other stockholder equity -129.07500M -94.53500M -68.88400M -51.58200M 9.87M
Property plant equipment 2.19M 2.60M 3.01M 2.85M 0.50M
Total current assets 163.79M 119.82M 87.57M 61.48M 52.46M
Long term investments - - - - -
Net tangible assets 117.43M 79.44M 61.67M 41.34M 31.12M
Short term investments 30.25M 26.90M 19.78M 19.78M 8.00M
Net receivables 39.88M 27.44M 22.84M 13.84M 17.42M
Long term debt - - - - -
Inventory 0.06M 0.08M 0.03M 0.04M 0.03M
Accounts payable 1.03M 1.64M 0.87M 0.83M 0.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 9.70M 7.20M 12.80M 8.60M 9.87M
Additional paid in capital - - - - -
Common stock total equity - - - 1.96M 1.96M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.60M 1.47M 1.39M 0.99M 0.52M
Deferred long term asset charges - - - - -
Non current assets total 38.34M 37.23M 38.01M 34.16M 31.82M
Capital lease obligations 1.85M 2.28M 2.62M 2.28M -
Long term debt total 1.20M 1.68M 2.04M 1.75M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -7.55700M -8.53300M -19.70400M -7.69900M -7.30500M
Change to liabilities 7.14M 8.10M 4.16M -1.32400M 7.29M
Total cashflows from investing activities -7.55700M -16.90700M -27.21700M -7.69900M -7.30500M
Net borrowings -0.57400M -0.50900M -0.50100M -0.55700M -0.55700M
Total cash from financing activities -27.52700M -23.31400M -14.04900M -12.31500M -9.84300M
Change to operating activities 0.27M 0.35M 0.26M -0.12900M 0.10M
Net income 60.65M 44.44M 30.85M 23.08M 19.12M
Change in cash 27.59M 21.62M -1.37400M 11.10M 7.08M
Begin period cash flow 63.66M 42.04M 43.41M 32.31M 25.24M
End period cash flow 91.25M 63.66M 42.04M 43.41M 32.31M
Total cash from operating activities 62.53M 61.58M 38.84M 31.42M 24.66M
Issuance of capital stock - - - - -
Depreciation 0.83M 0.81M 0.80M 0.84M 6.08M
Other cashflows from investing activities -1.11100M 0.65M 0.18M 0.17M 0.24M
Dividends paid 26.11M 18.79M 13.55M 10.92M 9.84M
Change to inventory 0.02M -0.04300M 0.00100M -0.00400M 0.02M
Change to account receivables -13.47800M -3.59100M -9.53900M 4.80M -9.08900M
Sale purchase of stock -0.84500M -4.01700M -4.01700M -0.84200M -0.84200M
Other cashflows from financing activities -0.57400M -0.50900M -0.50100M -0.55700M 0.84M
Change to netincome -0.24000M 0.40M 2.07M 3.63M 1.19M
Capital expenditures 6.45M 9.02M 7.69M 7.87M 7.55M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -13.45600M -3.63400M -9.53800M 4.79M -8.96100M
Stock based compensation 1.23M 0.03M 0.68M 0.65M 0.78M
Other non cash items 1.05M 16.32M 7.19M 7.50M 5.34M
Free cash flow 56.09M 52.55M 31.15M 23.55M 17.11M

Fundamentals

  • Previous Close 109.25
  • Market Cap11706.04M
  • Volume138030
  • P/E Ratio167.31
  • Dividend Yield0.33%
  • EBITDA96.08M
  • Revenue TTM142.12M
  • Revenue Per Share TTM1.36
  • Gross Profit TTM 126.79M
  • Diluted EPS TTM0.67

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PME
Pro Medicus Ltd		 2.85 2.61% 112.10 167.31 113.64 78.98 70.50 78.09 106.71
VHT
Volpara Health Technologies Ltd		 -0.005 0.44% 1.14 - - 7.65 6.53 7.78 -60.9831
CGS
CogState Ltd		 -0.03 2.14% 1.37 27.40 32.79 5.22 3.67 4.24 22.21
ONE
Oneview Healthcare PLC		 -0.015 5.45% 0.26 - - 26.22 16.80 25.10 -29.9289
M7T
Mach7 Technologies Ltd		 -0.01 1.41% 0.70 - - 6.26 3.10 8.57 -10.6285

Reports Covered

Stock Research & News

View All

Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Pro Medicus Ltd

450 Swan Street, Richmond, VIC, Australia, 3121

Key Executives

Name Title Year Born
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Exec. Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Exec. Director NA
Mr. Clayton James Hatch CPA, B.Comm, CPA CFO & Company Sec. NA
Dr. Malte Westerhoff GM of Europe & Global CTO NA
Mr. Brad Levin GM of North America & Global Head of Marketing NA
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc NA
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. NA
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director NA
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.